Managers from the Indiana University Innovation and Commercialization Office will share best practices and network with colleagues from around the country when they attend the sixth annual Big Ten Academic Alliance Technology Commercialization Roundtable in Chicago on Oct. 13. IU ICO attendees include Bill Brizzard, Jennifer Finefield, John Montgomery, Katherine Moynihan and David Wilhite. Wilhite… Read more »
Technology Commercialization
Approaching the Summit: Jennifer Finefield, IU Innovation and Commercialization Office
Jennifer Finefield, senior manager at the Indiana University Innovation and Commercialization Office, is one of the organizers of the Oct. 5 Commercialization and Entrepreneurship Summit on the IUPUI campus. The event will start at 8:30 a.m. in Hine Hall Auditorium, 875 W. North St. Finefield oversees patenting, marketing and licensing of technology emanating from the… Read more »
IU travels to Washington, D.C., to present Naval Surface Warfare Center, Crane Division’s impact on Midwest innovation
On Sept. 27, leaders from Naval Surface Warfare Center, Crane Division and other Indiana industry and academic partners traveled to Washington, D.C. They briefed representatives from the Office of the Vice President of the United States and the Office of Science and Technology Policy on the innovation ecosystem NSWC Crane has helped develop in Southern… Read more »
Approaching the Summit: Aoy Tomita-Mitchell, TAI Diagnostics and Ariosa Diagnostics
Aoy Tomita-Mitchell, co-founder of biotechnology companies TAI Diagnostics and Ariosa Diagnostics, will be a keynote speaker at the Oct. 5 Commercialization and Entrepreneurship Summit on the IUPUI campus. The event will start 8:30 a.m. at Hine Hall Auditorium, 875 W. North St. Tomita-Mitchell is a professor in the Department of Surgery, Division of Pediatric Cardiothoracic… Read more »
Approaching the Summit: Jesus Soriano, National Science Foundation
Jesus Soriano, program director at the National Science Foundation, will be a keynote speaker at the Oct. 5 Commercialization and Entrepreneurship Summit on the IUPUI campus. It will start at 8:30 a.m. in Hine Hall Auditorium, 875 W. North St. The event is open to the public, although registration is required. Women and underrepresented minorities… Read more »
Congratulations to Allinaire Therapeutics, which licenses IP developed at the IU School of Medicine
Allinaire Therapeutics has received $1.9 million in federal grants to support the development of treatments for lung diseases, including acute lung injury; Alpha-1 antitrypsin deficiency; and chronic obstructive pulmonary disease, or COPD. The company received a $1.67 million Phase II SBIR grant from the National Heart, Lung and Blood Institute and a $213,000 Discovery Award… Read more »
State business, academic and community leaders establish Applied Research Institute to generate tech transfer, commercialization activity
A new organization has been established by leaders in Indiana government, research universities, industry, and the largest military asset to generate technology transfer and commercialization in military defense and other sectors of the state’s economy. The Applied Research Institute provides streamlined access to more than $1 billion in state-of-the-art laboratories, equipment and research facilities across… Read more »
Director of the IU Innovation and Commercialization Office to promote university’s startup program on webinar
University leaders developing programs to encourage faculty entrepreneurship and startup creation, which can strengthen economic development in a region or state as inventions are developed and taken to market, will learn about one of the best programs in the country during a webinar next week. Dave Wilhite, director of the IU Innovation and Commercialization Office,… Read more »
Congratulations to Chondrial Therapeutics, which licenses Indiana University IP
Chondrial Therapeutics Inc. has been granted orphan drug status by the U.S. Food and Drug Administration for CTI-1601, its drug candidate to treat Friedreich’s ataxia. The Pennsylvania-based biotechnology company licenses intellectual property developed at the Indiana University School of Medicine. This IP was invented by Dr. R. Mark Payne, professor of pediatric cardiology at the… Read more »
IU School of Medicine researchers disclose more than 70 inventions in the 2016-17 fiscal year
Faculty, staff and student researchers at the Indiana University School of Medicine reported 73 inventions during the fiscal year July 1, 2016, to June 30, 2017. Over the last two fiscal years, IU School of Medicine researchers disclosed 147 inventions. Disclosures were made to Indiana University Research and Technology Corp., which served to protect, market… Read more »